EFMC-ISMC 2008

XXth International Symposium on Medicinal Chemistry

 Vienna, Austria, August 31    September 4, 2008

Programme

Please download here the attached Excel file with the complete programme.

Plenary Lectures

Award Lectures

The UCB-Ehrlich Award for Excellence in Medicinal Chemistry (EFMC)
Automated Oligosaccharide Synthesis as Platform for Vaccine Development

Prof. Peter H. SEEBERGER
MAX PLANCK INSTITUTE OF COLLOIDS AND INTERFACES, Berlin, Germany

GlaxoSmithKline Award forOutstanding Achievement in the Field of Chemical Biology
Exploring Chemical Space with Aptamers

Dr. Michael FAMULOK
UNIVERSITY OF BONN, Bonn, Germany

Start of sessions

1. Novel Lead Finding Approaches
2. Chemistry Strategies to Reduce Attrition in Drug Discovery
3. Emerging Drugs
1. Novel Lead Finding Approaches
Prof. Hans Ulrich STILZ (Session Chair)
SANOFI-AVENTIS, Malov, Denmark
2. Chemistry Strategies to Reduce Attrition in Drug Discovery
Dr Geoffrey STEMP (Session Chair)
GLAXOSMITHKLINE, Harlow, United Kingdom
3. Emerging Drugs
Dr Bernd RIEDL (Session Chair)
BAYER PHARMA, Wuppertal, Germany

Start of sessions

4. Kinase Selectivity-Is it Necessary? (ACS)
5. Predictive ADME/Tox Methods: What to Apply When?
6. Macromolecular and Polymeric Drugs
4. Kinase Selectivity-Is it Necessary? (ACS)
Development of Dibenzosuberones as Potent and Highly Selective p38 MAPK Inhibitors
Prof. Stefan LAUFER
UNIVERSITY OF TUEBINGEN, Tübingen, Germany
5. Predictive ADME/Tox Methods: What to Apply When?
Dr Scott BOYER (Session Chair)
ASTRAZENECA, Södertälje, Sweden
6. Macromolecular and Polymeric Drugs
Prof. Abraham J. DOMB (Session Chair)
HEBREW UNIVERSITY OF JERUSALEM, Jerusalem, Israel

Start of sessions

7. Fragment-Based Drug Discovery (ACS)
8. Imaging Ligands and Biomarkers (EUFEPS)
9. Natural Products as Starting Points in Drug Discovery
7. Fragment-Based Drug Discovery (ACS)
EVOlution: Design and Implementation of a Fragment Discovery Platform
Dr. John BARKER
EVOTEC, OXON, United Kingdom
8. Imaging Ligands and Biomarkers (EUFEPS)
Prof. Pia VUORELA (Session Chair)
ÅBO AKADEMI UNIVERSITY, Turku, Finland
9. Natural Products as Starting Points in Drug Discovery
Dr. Erden BANOGLU (Session Chair)
GAZI UNIVERSITY, Ankara, Turkey

Start of sessions

10. Neurodegenerative Diseases
11. Type 2 Diabetes
12. Progress in COPD and Asthma Therapy
10. Neurodegenerative Diseases
Prof Magid ABOU-GHARBIA (Session Chair)
TEMPLE UNIVERSITY, Philadelphia, United States
11. Type 2 Diabetes
DPP-4 Inhibitors: Galvus® / Vildagliptin and Following Generations
Dr. Daniel BAESCHLIN
NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, Basel, Switzerland
12. Progress in COPD and Asthma Therapy
Dr. Matthias GRAUERT (Session Chair)
BOEHRINGER INGELHEIM, Biberach, Germany

Start of sessions

13. Allosteric Modulation and GPCR Drug Discovery
14. Oncology
15. Immunology & Immunomodulation
13. Allosteric Modulation and GPCR Drug Discovery
Prof. Rob LEURS (Session Chair)
VU UNIVERSITY AMSTERDAM, Amsterdam, The Netherlands
14. Oncology
Dr Jeremy DAVIS (Session Chair)
UCB, Slough, United Kingdom
15. Immunology & Immunomodulation
Dr Katerina LEFTHERIS (Session Chair)
VITAE PHARMACEUTICALS, South San Francisco, United States

Start of sessions

16. Antispsychotic Targets
17. Antivirals
18. Pain
16. Antispsychotic Targets
Dopamine System Stabilizers
Prof. György DOMANY
GEDEON RICHTER PLC, Budapest, Hungary
17. Antivirals
Dr Maria Jose CAMARASA (Session Chair)
CSIC, Madrid, Spain
18. Pain
Dr Erin DIMAURO (Session Chair)
AMGEN, Cambridge, United States

Start of sessions

19. Exploring the Chemical Space
20. Chemokines
21. Systems Level Research Informs Drug Target Identification and Therapy Design
19. Exploring the Chemical Space
Profs. Herbert WALDMANN & STEFAN WETZEL (Session Chair)
MAX PLANCK INSTITUTE OF MOLECULAR PHYSIOLOGY, Dortmund, Germany
20. Chemokines
Prof. Gerhard ECKER (Session Chair)
UNIVERSITY OF VIENNA, Vienna, Austria
21. Systems Level Research Informs Drug Target Identification and Therapy Design
Prof. Harel WEINSTEIN (Session Chair)
CORNELL UNIVERSITY, New York, United States

Start of sessions

22. New Computational Approaches Supporting Drug Design
23. Druggability of Protein-Protein Interactions
24. Systems Biology and Medicinal Chemistry
22. New Computational Approaches Supporting Drug Design
Prof. Jordi MESTRES (Session Chair)
IMIM AND UNIVERSITY POMPEU FABRA, Barcelona, Spain
23. Druggability of Protein-Protein Interactions
Dynamic Ligation Screening: A Method for the Site-Directed Discovery of Inhibitory Fragments
Prof Jörg RADEMANN
UNIVERSTITÄT LEIPZIG, Leipzig, Germany
24. Systems Biology and Medicinal Chemistry
Prof Christian NOE (Session Chair)
UNIVERSITY OF VIENNA, Vienna, Austria

Start of sessions

25. Structure Based Drug Design (AFMC)
26. Modulators of Adenosine and P2Y Receptors
27. Addressing Therapeutic Complexity in Oncology with Med. Chem.
25. Structure Based Drug Design (AFMC)
Prof. Esin AKI-SENER (Session Chair)
ANKARA UNIVERSITY, Ankara, Turkey
26. Modulators of Adenosine and P2Y Receptors
Prof. Kenneth A. JACOBSON (Session Chair)
NIDDK, Bethesda, United States
27. Addressing Therapeutic Complexity in Oncology with Med. Chem.
Dr Janet ROBERTSON (Session Chair)
TES PHARMA, Corciano , Italy

FORUM DISCUSSION

A.Golinowska3 LINK TO FORUM DISCUSSION PARTICIPANTS

How to close the gap between academic training in medicinal chemistry and industrial reality?

Moderator

Prof. Péter MÁTYUS
SEMMELWEIS UNIVERSITY, Budapest, Hungary

WORKSHOPS

ACCELRYS NIKEM LINK TO WORKSHOPS DESCRIPTION

ACCELRYS

A.Golinowska COOL TOOLS FROM ACCELRYS: HELPING TO AUTOMATE MEDICINAL CHEMISTRY EVERYDAY TASKS
BIOVIA, Belgium

NIKEM RESEARCH

A.Golinowska2 FROM IDEAS TO PRECLINICAL CANDIDATES: MEDCHEM-DRIVEN DRUG DISCOVERY AT NIKEM

STRATEGIES FOR THE DISCOVERY OF INNOVATIVE THERAPEUTICS

Prof Magid ABOU-GHARBIA
TEMPLE UNIVERSITY, Philadelphia, United States

Life on the Edge: The Nature and Origins of Protein Misfolding Diseases

Prof. Chris DOBSON
UNIVERSITY OF CAMBRIDGE, Cambridge, United Kingdom

Drug Discovery for Neglected Diseases

Prof. Paul HERRLING
NOVARTIS INTERNATIONAL, Basel, Switzerland

Chemical Tools for the Study of Complex Biological Systems

Prof. Barbara IMPERIALI
MASSACHUSETTS INSTITUTE OF TECHNOLOGY, Cambridge, United States

The Nauta Award for Pharmacochemistry (EFMC)
Changing Paradigms in Drug Discovery

Prof. Hugo KUBINYI
UNIVERSITY OF HEIDELBERG, Weisenheim am Sand, Germany

The Prous Institute-Overton and Meyer Award for New Technologies in Drug Discovery (EFMC)
New Tools for Molecule Makers: Emerging Technologies

Prof. Steven V. LEY
UNIVERSITY OF CAMBRIDGE, Cambridge, United Kingdom